z-logo
open-access-imgOpen Access
Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
Author(s) -
Peter Cashin,
Lana Ghanipour,
Malin Enblad,
David L. Morris
Publication year - 2020
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v12.i5.549
Subject(s) - medicine , neutropenia , oxaliplatin , hazard ratio , surgery , colorectal cancer , chemotherapy , irinotecan , oncology , confidence interval , gastroenterology , cancer
The implications of neutropenia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) treatment have never been investigated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here